NewsRoom Articles - Page 58 of 222

WednesdayJan 03, 2024 10:33 am

Shining Spotlight on How Vitiligo Could Be Connected to Other Autoimmune Disorders

Vitiligo is an autoimmune condition that affects melanin, the pigmentation in the skin, and results in the development of pale-white patches on the skin. It occurs when a person’s immune system becomes dysfunctional and begins to attack melanin cells in the skin, killing the cells off and causing skin regions without pigment cells to become paler. The American Academy of Dermatology notes that there are several types of vitiligo depending on how the patches appear, how much of the skin they cover and their rate of spread. Localized vitiligo typically causes a few patches over small areas of the body,…

TuesdayJan 02, 2024 10:19 am

Study Shows Ongoing Benefits Once Immunotherapy Stops

A study from the University of Texas MD Anderson Cancer Center’s Department of Gastrointestinal Medical Oncology has found that some patients continue to benefit from immunotherapy once the treatment stops. Researchers found that some metastatic colorectal cancer patients are reluctant to stop the treatment as per their doctors’ recommendations, suggesting that discontinuing the treatment doesn’t always stop its benefits. University of Texas MD Anderson Cancer Center associate professor and senior study author Dr. Van Morris and his research team wanted to determine if the health benefits of immunotherapy continued once the treatment was discontinued or due to side effects. The…

TuesdayJan 02, 2024 9:00 am

Clene Inc.’s (NASDAQ: CLNN) Phase 2 REPAIR-PD and REPAIR-MD Trials Indicate CNM-Au8(R)’s Ability to Increase Key Brain Metabolites, Supporting Advancement to Phase 3 Trials

Clene Inc., a late clinical-stage biopharmaceutical company focused on developing solutions that improve mitochondrial health and protect neuronal function to treat neurodegenerative diseases, recently announced the publication of a peer-reviewed article The article describes results from two Phase 2a clinical trials, REPAIR-PD and REPAIR-MS, which evaluated the effects of CNM-Au8, the company’s lead drug candidate, on brain energy metabolite levels in participants with Parkinson’s Disease and Multiple Sclerosis, respectively Researchers measured key brain metabolites, such as NADH and NAD+, which are involved in neuronal energy production, utilization, and maintenance, for changes from baseline with daily, oral treatment of CNM-Au8 over…

FridayDec 29, 2023 12:13 pm

Highlights from Earnings Results of Major e-Commerce Sector Players

As the holiday shopping season draws to a close, more players in the e-commerce sector are reporting their earnings for the year. Below, we look at some of the major fulfillment vendors and retailers that announced earnings from their recent fiscal quarters. Amazon.com Inc. reported its highest operating income ever in its third quarter, raking in $143.1 billion. This increase represents a 343% growth, year over year (y-o-y). Walmart Inc.’s report shows that online sales in the United States rose by 24% for its 2023 fiscal third quarter. Over the same period, international e-commerce sales role 15% while global e-commerce…

ThursdayDec 28, 2023 12:10 pm

Light, Viruses Could Transform Brain-Tumor Treatment

A biomedical researcher from Spain has spent the past several years working on a novel brain-tumor treatment that would expand the boundaries of medical innovation to unseen territories. Dr. Marta Alonso shifted her focus to pediatric brain tumors after she met a teenager with medulloblastoma at the MD Anderson Cancer Center in Houston more than 15 years ago. Medulloblastoma is a common pediatric cancerous brain tumor that typically starts growing in the cerebellum, the lower back region of the brain that is involved in movement, balance and muscle coordination. Treatment protocols for the pediatric cancer involve surgery, radiation, and chemotherapy,…

WednesdayDec 27, 2023 3:14 pm

FDA Announces Changes to Safety Labeling Requirements for Opioid Medications

The U.S. Food and Drug Administration has announced that changes to safety labeling requirements for opioid medications are receiving final approval and implementation. These changes are part of the agency’s ongoing efforts to address the country’s opioid overdose epidemic, a crisis that has taken tens of thousands of American lives over the past several decades and is still one of the most prolific killers in the country. The changes were first announced in April 2023 when the FDA notified application holders of Abbreviated New Drug Applications (ANDAs) and New Drug Applications of the impending arrival of saget labeling updates for…

TuesdayDec 26, 2023 11:16 am

Israeli Study Offers Hope to Sleeping Sickness Patients

A multi-institutional team of Israeli researchers has made a breakthrough that could lead to more effective treatments for sleeping sickness, or trypanosomiasis. The condition is caused by Trypanosoma brucei, a microscopic parasite that is transmitted by the tsetse fly and is often fatal when left untreated. A joint Israeli research team from the Weizmann Institute in Rehovot and Bar-Ilan University (BIU) in Ramat Gan has now found that damaging the protein-production capacity essentially neutralizes the sleeping sickness parasite. Conducted by Nobel Prize laureate and BIU professor Shumali Michaeli and Weizmann Institute professor of chemical and structural engineering Ada Yonath, the…

FridayDec 22, 2023 2:27 pm

Studies Suggest Fasting Could Tone Down Alzheimer’s Signs

It is estimated that more than six million Americans suffer from Alzheimer’s, with data from the Alzheimer’s Association showing that every 67 seconds, another individual develops the illness. This progressive illness affects parts of the brain that control memory, thought and language. A common symptom that many patients experience first is mild loss of memory. Researchers believe that Alzheimer’s is caused by the buildup of proteins around and in brain cells. One of the primary proteins involved is the amyloid protein. Some studies have posited that what individuals eat can help slow or prevent the progression of this form of…

ThursdayDec 21, 2023 3:51 pm

Finnish Study Suggests Exercise Plays Smaller Role in Longevity

Common knowledge coupled with numerous polls on lifestyle and longevity indicate that exercise generally contributes to longer lives. Physicians consistently encourage their patients to exercise regularly, and many experts contend that the modern sedentary lifestyle has significantly contributed to poor health and reduced lifetimes. However, a recent Finnish Twins Cohort Study report has suggested that exercise may not be as integral to longevity as previously thought. The report notes that “leisure time physical activity” has little direct effect on lifespan, questioning the conventional knowledge that incorporating exercise into your lifestyle can help you live longer. Generally, an individual’s lifespan is…

WednesdayDec 20, 2023 2:30 pm

New Research Redefines Pathophysiology of Rheumatoid Arthritis, Paves Way for Precision Treatments

A recent paper that was published in the “Nature" journal has redefined rheumatoid arthritis (RA) and potentially opened the door to the development of targeted therapies. Researchers analyzed tissue collected from the synovial joints of almost 80 people diagnosed with moderate to high rheumatoid arthritis and built up a massive atlas of RA synovial changes from more than 314,000 single cells. This atlas could potentially lead to the development of targeted therapies that take into account the diversity of the rheumatoid arthritis disease process. Rheumatoid arthritis is an autoimmune disease that typically affects joints in the wrists, hands and knees. The…